BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

Active, not recruiting

Phase 3 Results N/A

Eligibility Criteria

Inclusion Criteria

- Minimum weight of 10 kg/22 lb
- Upper limb spasticity due to cerebral palsy or stroke

Exclusion Criteria

- Muscular dystrophy, myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or mitochondrial disease
- Uncontrolled epilepsy
- Botulinum Toxin therapy of any serotype for any condition within the last 3 months
- History of surgical intervention of the upper limb within 1 year, or planned surgery of any limb during the study